goralatide has been researched along with carboplatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappelaere, P; Carde, P; Chauvergne, J; De Gislain, C; Domenge, C; Dufour-Esquerré, F; Hecquet, B; Krakowski, I; Meeus, L; Rolland, F | 1 |
| Deschamps de Paillette, E; Filipski, E; Lévi, F; Li, XM; Soulard, C | 1 |
1 trial(s) available for goralatide and carboplatin
| Article | Year |
|---|---|
[Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Hematopoietic Stem Cells; Humans; Male; Middle Aged; Oligopeptides; Placebos | 1995 |
1 other study(ies) available for goralatide and carboplatin
| Article | Year |
|---|---|
Circadian-based effects of AcSDKP, with or without rhG-CSF on hematologic toxicity of chemotherapy in mice.
Topics: Analysis of Variance; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Carboplatin; Circadian Rhythm; Cytarabine; Granulocyte Colony-Stimulating Factor; Growth Inhibitors; Humans; Male; Mice; Oligopeptides | 1998 |